Ibere Pharmaceuticals OverviewIbere Pharmaceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for IBER.
Quarterly EBIT
-$233.60K
↑ 25.96% YoY
As of Sep 30, 2022
Annual EBIT (TTM)
-$1.04M
Trailing 12 months ending Sep 30, 2022
Ibere Pharmaceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for IBER.
As of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022